autologous cultured chondrocytes on porcine collagen membrane · Maci
Cell therapy
Evidence outlook
Approved: Cartilage Defects of the Knee
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
| Trial | Phase | Endpoint | Key result | Signal | Source |
|---|---|---|---|---|---|
SUMMIT NCT00719576 · Cartilage Defects of the Knee This was a randomized trial against microfracture surgery, but it was open-label, and its primary endpoint is a patient-reported pain and function score that knowledge of the treatment could influence. MACI improved the combined KOOS pain and sports-function endpoint more than microfracture at two years (p=0.001). Registry: NCT00719576 | 3 | Change From Baseline to Week 104 for the Participant's Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain and Function (Sports and Recreational Activities) Scores. (Baseline and Week 104) 2012-03 | Change from baseline to week 104, MACI vs microfracture: KOOS Pain +45.45 vs +35.23 and KOOS Function (sports and recreation) +46.04 vs +35.83; co-primary MANOVA p=0.001 (n=72 each) (CT.gov posted results). | Partial signal | link ↗ |
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 3 (3)
What this study did
What this study did
What this study did
Competitive landscape
No competitors sharing a mechanism or indication in the current universe.
Upcoming events
(2 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow Maci (autologous cultured chondrocytes on porcine collagen membrane) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.